USPTO serial 88360709
KULTLEAF
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KULTLEAF?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Pointe Claire, Quebec, CA
Pointe Claire, Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Craig R. Rogers
Craig R. Rogers SIMPLE IP LAW, P.C.19555 SW 53RD AVE.TUALATIN, OR 97062UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Oils for cosmetic purposes, including essential oils used in the preparation and production of creams, ointments, pomades, topical oils, soaps, bandages, and other cosmetic or topical skin treatments; Ethereal oils; Essential oils; Essential oils used as cake flavorings and food flavorings for human or animal consumption, including essential oils used in the preparation and production of food flavorings for food products such as baked or confectionary goods; Essential oils used as aromatics; Essential oils used as flavorings for beverages, including essential oils used in the preparation and production of beverages such as beer, alcoholic drinks, non-alcoholic drinks, mixed drinks and other cocktails, energy drinks, teas, isotonic beverages, soft drinks, juices, waters, and elixirs | ACTIVE | — |
| 005 | Adjuvants for medical purposes; Analgesics; Antibacterial soap; Antibacterial handwashes; Antiseptics; Capsules sold empty for medicines; Chemical preparations for pharmaceutical purposes, namely, pharmaceuticals for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, Crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Chemical preparations for medical purposes, namely, pharmaceuticals for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Chemical preparations for veterinary purposes, namely, pharmaceuticals for treating inflammation, arthritis, nausea, loss of appetite, gastrointestinal disorders, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, pains, and for improving mobility and flexibility in animals, and for use as an anti-septic, anti-fungal, and anti-bacterial; Chemical reagents for medical or veterinary purposes; Chemico-pharmaceutical preparations, namely, for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Decoctions for pharmaceutical purposes, namely, for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Disinfectant soap; Disinfectants for hygiene purposes; Disinfectants for chemical toilets; Disinfectants; Dietary supplements intended to supplement a normal diet or to have health benefits; Drugs for medical purposes, for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Pharmaceutical preparations, namely, Elixirs for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Extracts of hops for pharmaceutical purposes; Flour for pharmaceutical purposes; Meal for pharmaceutical purposes; Freeze-dried food adapted for medical purposes; Lyophilized food adapted for medical purposes; Gelatine for medical purposes, namely, gelatine capsules sold empty for pharmaceuticals; Greases for medical purposes; Greases for veterinary purposes; Chewing gum for medical purposes; Herbal teas for medicinal purposes; Herbal extracts for medical purposes; Homogenized food adapted for medical purposes; Medicinal infusions for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Medicinal tea; Medicinal oils; Medicinal herbs; Medicinal drinks; Medicated shampoos, soaps, lotions for skin, hair, face, and body, and dentifrices; Medicines for alleviating constipation; Mouthwashes for medical purposes; Nutraceutical preparations for therapeutic or medical purposes; Ointments for pharmaceutical purposes, namely, antibiotic ointment, medicated sunburn ointment, anti-itch ointment, topical preparations for skin treatment; Pharmaceutical preparations for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Pharmaceutical preparations for skin care; Pharmaceuticals for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial; Sedatives; Tranquillizers; Personal sexual lubricants; Sexual stimulant gels; Tissues impregnated with pharmaceutical lotions, namely, medicated skin lotions; Smoking herbs for medical purposes; Tobacco-free cigarettes for medical purposes, namely, for treating inflammation, arthritis, insomnia, depression and other anxiety related conditions, nausea, loss of appetite, crohn's disease and other gastrointestinal disorders, epilepsy, turrets, Alzheimer's, Parkinson's, ALS, PTSD, ADD and ADHD, seizures and other neurological conditions, muscle spasms, cardiovascular conditions, diabetes, migraines, headaches and other pains, and for improving mobility and flexibility, for use as a calming aid, and for pain management conditions, and for use as an anti-septic, anti-fungal, and anti-bacterial, and for smoking cessation | ACTIVE | — |
| 030 | Flavorings, other than essential oils, namely, extracts used as flavorings for food products or beverages; Flavorings, other than essential oils, for cakes; Food flavorings, other than essential oils; Flavorings, other than essential oils, for beverages; Essences for foodstuffs, except etheric essences and essential oils, namely, extracts used as food flavorings | ACTIVE | — |
| 032 | Beer; Beer-based cocktails; Preparations for making beverages, namely, beer, carbonated non-alcoholic drinks, energy drinks, isotonic beverages, soft drinks, fruit and vegetable juices and water: Non-alcoholic cocktails; Energy drinks; Essences for making beverages, namely, beer, carbonated non-alcoholic drinks, energy drinks, isotonic beverages, soft drinks, fruit juices and water; Isotonic beverages; Non-alcoholic beverages, namely, energy drinks, isotonic beverages, soft drinks, fruit and vegetable juices, and water; Non- alcoholic beverages flavored with coffee; Non-alcoholic beverages flavored with tea; Soft drinks | ACTIVE | — |
| 034 | Flavorings, other than essential oils, for tobacco; Flavorings, other than essential oils, for use in electronic cigarettes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharmaguild Inc.
- Other trademarks owned by Pharmaguild Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 034
- Similar marks named KULTLEAF
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2021 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 17, 2021 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 23, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 21, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 21, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 21, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 14, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 18, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 18, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 29, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 13, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 13, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 13, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 13, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 8, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 31, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 10, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 10, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 1, 2019 | NWAP | NEW APPLICATION ENTERED | — |